TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
-3.25%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.29B
AUM Growth
-$158M
(-6.5%)
Cap. Flow
-$50.3M
Cap. Flow
% of AUM
-2.19%
Top 10 Holdings %
Top 10 Hldgs %
41.8%
Holding
210
New
13
Increased
53
Reduced
56
Closed
18
Top Buys
| 1 |
Merck
MRK
|
$16.6M |
| 2 |
Illumina
ILMN
|
$13M |
| 3 |
Humana
HUM
|
$9.23M |
| 4 |
Biogen
BIIB
|
$7.74M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.28M |
Top Sells
| 1 |
Amgen
AMGN
|
$18.8M |
| 2 |
Abbott
ABT
|
$15.2M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$15M |
| 4 |
Thermo Fisher Scientific
TMO
|
$13.7M |
| 5 |
Eli Lilly
LLY
|
$10.8M |
Sector Composition
| 1 | Healthcare | 94.94% |
| 2 | Real Estate | 3.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Ionis Pharmaceuticals
IONS
$9.44B
| $11.2M | 0.49% |
186,244
+58,646
| +46% | +$3.51M |
|
52
Sabra Healthcare REIT
SBRA
$4.56B
| $10.7M | 0.47% |
466,247
| – | – |
|
53
Zimmer Biomet
ZBH
$20.7B
| $10.6M | 0.46% |
79,898
-2,146
| -3% | -$286K |
|
54
Sarepta Therapeutics
SRPT
$1.94B
| $10.6M | 0.46% |
140,279
-7,568
| -5% | -$570K |
|
55
Ventas
VTR
$30.7B
| $10.3M | 0.45% |
141,119
+42,623
| +43% | +$3.11M |
|
56
GSK
GSK
$79.6B
| $9.89M | 0.43% |
185,406
+10,446
| +6% | +$557K |
|
57
Jazz Pharmaceuticals
JAZZ
$7.78B
| $9.6M | 0.42% |
74,936
+7,465
| +11% | +$957K |
|
58
FibroGen
FGEN
$46.2M
| $8.62M | 0.38% |
9,326
-447
| -5% | -$413K |
|
59
Esperion Therapeutics
ESPR
$516M
| $7.83M | 0.34% |
213,562
+28,955
| +16% | +$1.06M |
|
60
NovoCure
NVCR
$1.35B
| $7.55M | 0.33% |
100,932
+46,858
| +87% | +$3.5M |
|
|
LTC
61
LTC Properties
LTC
$1.67B
| $7.45M | 0.32% |
145,421
| – | – |
|
62
Ascendis Pharma
ASND
$12.1B
| $7.43M | 0.32% |
77,167
+3,520
| +5% | +$339K |
|
|
GWPH
63
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $7.42M | 0.32% |
64,499
| – | – |
|
|
BPMC
64
DELISTED
Blueprint Medicines
BPMC
| $7.41M | 0.32% |
100,916
+5,940
| +6% | +$436K |
|
65
Dentsply Sirona
XRAY
$2.85B
| $7.3M | 0.32% |
136,936
+10,015
| +8% | +$534K |
|
66
SPDR S&P Biotech ETF
XBI
$5.26B
| $6.79M | 0.3% |
89,022
| – | – |
|
|
MDCO
67
DELISTED
Medicines Co
MDCO
| $6.78M | 0.3% |
135,675
-142,417
| -51% | -$7.12M |
|
|
IMMU
68
DELISTED
Immunomedics Inc
IMMU
| $6.46M | 0.28% |
487,103
+97,790
| +25% | +$1.3M |
|
|
MRTX
69
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $6.21M | 0.27% |
79,687
+66,097
| +486% | +$5.15M |
|
70
Bio-Techne
TECH
$8.23B
| $5.98M | 0.26% |
122,148
+35,344
| +41% | +$1.73M |
|
71
Exelixis
EXEL
$9.97B
| $5.87M | 0.26% |
331,751
-346,716
| -51% | -$6.13M |
|
72
Smith & Nephew
SNN
$16.4B
| $5.86M | 0.26% |
121,645
-39,089
| -24% | -$1.88M |
|
|
HZNP
73
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.85M | 0.26% |
214,730
+57,257
| +36% | +$1.56M |
|
74
Sutro Biopharma
STRO
$86.5M
| $5.83M | 0.25% |
641,268
| – | – |
|
|
ABMD
75
DELISTED
Abiomed Inc
ABMD
| $5.82M | 0.25% |
32,716
| – | – |
|